SARS-CoV-2 Omicron Spike recognition by plasma from individuals receiving BNT162b2 mRNA vaccination with a 16-week interval between doses
Authors:
Open Access
- 8 February 2022
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 38 (9) , 110429
Abstract
No abstract availableKeywords
All Related Versions
This publication has 40 references indexed in Scilit:
- Introduction of the South African SARS-CoV-2 variant 501Y.V2 into the UKJournal of Infection, 2021
- Updated rapid risk assessment from ECDC on the risk related to the spread of new SARS-CoV-2 variants of concern in the EU/EEA – first updateEurosurveillance, 2021
- Susceptibility of rabbits to SARS-CoV-2Emerging Microbes & Infections, 2021
- Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody RecognitionCell Host & Microbe, 2021
- Escape from neutralizing antibodies by SARS-CoV-2 spike protein variantseLife, 2020
- Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent IndividualsmBio, 2020
- Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 SpikeCell Reports Medicine, 2020
- Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodiesScience, 2020
- Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spikeNature, 2020
- A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiologyNature Microbiology, 2020